Personalized Liposomal Neoantigen-based Peptide Vaccine EVX-01

**Semantic type:** Immunologic Factor|Pharmacologic Substance

**Definition:** A personalized liposomal peptide vaccine composed of specific cancer neoepitopes, which are highly patient-specific immunogenic tumor associated antigens (TAAs), with potential immunostimulatory and antineoplastic activities. Upon administration of the personalized liposomal neoantigen-based peptide vaccine EVX-01, the neoepitopes induce cytotoxic T-lymphocyte (CTL)-mediated immune responses against tumor cells expressing these specific TAAs.

**Synonyms:** - EVX 01 - EVX-01 - EVX01 - Liposomal Peptide Vaccine EVX-01 - Liposomal Peptide-based Vaccine EVX-01